Our Services
Medical Information
Helpful Resources
Published on: 6/16/2026
Hyperparathyroidism occurs when overactive parathyroid glands release too much parathyroid hormone, causing calcium to accumulate in the bloodstream. Common symptoms include fatigue, bone pain, kidney stones, abdominal discomfort, and cardiovascular issues.
There are three types: primary (often caused by a benign tumor), secondary (typically due to vitamin D deficiency or chronic kidney disease), and tertiary (long-standing secondary disease). Treatment varies—ranging from surgery and medications to active monitoring—based on type, severity, and symptoms.
Because hyperparathyroidism shares symptoms with many other conditions, identifying the cause early is essential. Take a free, instant, online symptom check to clarify what your symptoms may mean and confidently determine your next steps.
Reviewed for medical accuracy: 06/16/2026
Hyperparathyroidism is a condition where your parathyroid glands produce too much parathyroid hormone (PTH). These four tiny glands, located behind your thyroid in the neck, regulate calcium levels in your blood. When PTH levels are too high, calcium accumulates in the bloodstream, leading to a range of symptoms and potential complications.
There are three main types:
Primary hyperparathyroidism
• Most common form
• Usually caused by a benign growth (adenoma) on one of the parathyroid glands
• Leads to overproduction of PTH and high blood calcium
Secondary hyperparathyroidism
• Occurs when a chronic condition—like kidney disease or vitamin D deficiency—lowers blood calcium
• Parathyroid glands ramp up PTH production to compensate
Tertiary hyperparathyroidism
• Develops after longstanding secondary hyperparathyroidism
• Glands become permanently overactive even if the original trigger is corrected
Parathyroid hormone plays three main roles:
When PTH is too high, these mechanisms overshoot, causing persistent hypercalcemia (high blood calcium).
Symptoms can be subtle or vague, especially in early stages. Common signs include:
Because these symptoms overlap with many other conditions, hyperparathyroidism often goes undiagnosed for months or years.
If left untreated, chronic high calcium levels can lead to:
Kidney stones
• Calcium crystallizes in the urine
• Painful stones can damage the kidneys over time
Bone loss and fractures
• Excessive PTH breaks down bone tissue
• Leads to osteoporosis and increased fracture risk
Cardiovascular issues
• High calcium may contribute to high blood pressure
• Potential risk for irregular heart rhythms (arrhythmias)
Gastrointestinal problems
• Pancreatitis (inflammation of the pancreas)
• Peptic ulcers
Certain factors increase the likelihood of hyperparathyroidism:
If your healthcare provider suspects hyperparathyroidism, they may order:
Blood tests
Urine tests
Imaging studies
A thorough medical history and physical exam help rule out secondary causes (e.g., vitamin D deficiency, kidney disease).
Treatment depends on the type and severity of hyperparathyroidism, your symptoms, and overall health.
Primary hyperparathyroidism: Surgery is the definitive treatment for most patients, especially if:
Procedure: Minimally invasive parathyroidectomy to remove the overactive gland(s)
Success rate: Over 95% in experienced hands
Recovery: Most people go home the same day or after an overnight stay
Hyperparathyroidism can develop slowly and silently. If you've noticed any of the symptoms above or face persistent unexplained fatigue, use Ubie's free AI-powered Hyperparathyroidism symptom checker to better understand what might be causing your concerns and when you should seek medical care.
Don't delay medical evaluation if you experience:
Always speak to a doctor about any concerning symptoms, especially those that could be serious or life-threatening.
If you suspect your calcium levels are consistently high or you're experiencing related symptoms, consult your healthcare provider. Early intervention can protect your bones, kidneys, and heart.
(References)
* Bilezikian JP. Primary Hyperparathyroidism: An Update. J Clin Endocrinol Metab. 2021 Jul 16;106(8):2111-2122. doi: 10.1210/clinem/dgab099. PMID: 33596041.
* Valle M, et al. Hyperparathyroidism. Lancet. 2023 Feb 11;401(10375):525-538. doi: 10.1016/S0140-6736(22)01518-8. PMID: 36774916.
* Shoback DM, et al. The Changing Face of Primary Hyperparathyroidism: Etiology, Epidemiology, Pathophysiology, and Medical Management. Endocr Rev. 2020 Jun 1;41(3):bnza008. doi: 10.1210/endrev/bnza008. PMID: 32267597.
* Marcocci C, et al. Primary Hyperparathyroidism. Nat Rev Dis Primers. 2019 Jul 18;5(1):47. doi: 10.1038/s41572-019-0106-9. PMID: 31320621.
* Khan AA, et al. Primary Hyperparathyroidism: Diagnosis and Management. J Bone Miner Res. 2017 Jul;32(7):1365-1376. doi: 10.1002/jbmr.3149. Epub 2017 Apr 28. PMID: 28370933.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.